DNA Topoisomerases as Anticancer Drug Targets: From the Laboratory to the Clinic
Current Medicinal Chemistry-Anti-Cancer Agents · 2001
DOI: 10.2174/1568011013354859 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Medicinal Chemistry-Anti-Cancer Agents, 2001. Verfasst von J A Holden. Beteiligte Einrichtung: Department of Pathology, University of Utah, Salt Lake City 84132, USA. joe.holden@path.med.utah.edu. Hauptthemen laut MEDLINE: Topoisomerase Inhibitors. Die Arbeit wurde bisher 82-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University of Utah, Salt Lake City 84132, USA. joe.holden@path.med.utah.edu
Zitieren
APA
Holden, J. A. (2001). DNA Topoisomerases as Anticancer Drug Targets: From the Laboratory to the Clinic. Current Medicinal Chemistry-Anti-Cancer Agents. https://doi.org/10.2174/1568011013354859
Vancouver
Holden JA. DNA Topoisomerases as Anticancer Drug Targets: From the Laboratory to the Clinic. Current Medicinal Chemistry-Anti-Cancer Agents. 2001. doi:10.2174/1568011013354859
BibTeX
@article{Holden2001,
author = {Holden, J A},
title = {DNA Topoisomerases as Anticancer Drug Targets: From the Laboratory to the Clinic},
journal = {Current Medicinal Chemistry-Anti-Cancer Agents},
year = {2001},
doi = {10.2174/1568011013354859}
}
EUVIMED